Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy of non-metastatic ewing sarcoma.

G Prindull, H Jürgens, F Jentsch

    Journal of Cancer Research and Clinical Oncology
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

    Bone marrow transplantation·2021
    Same author

    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.

    Bone marrow transplantation·2021
    Same author

    [Not Available].

    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
    Same author

    [Adherence to Long-term Follow-up in Paediatric Oncology--Results of a Monocentric Analysis].

    Klinische Padiatrie·2015
    Same author

    ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    [The first KiGGS follow-up (KiGGS Wave 1): study conduct, sample design, and response].

    Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
    Same journal

    GALNT5 drives colorectal cancer progression and chemoresistance via PI3K/Akt/ABCC1 axis.

    Journal of cancer research and clinical oncology·2026
    Same journal

    Editorial Expression of Concern: Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.

    Journal of cancer research and clinical oncology·2026
    Same journal

    Nano-biosensors for circulating tumor markers: advancing liquid biopsy toward precision cancer diagnostics.

    Journal of cancer research and clinical oncology·2026
    Same journal

    Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients.

    Journal of cancer research and clinical oncology·2026
    Same journal

    Stained region lymph node biopsy for axillary restaging after neoadjuvant systemic therapy in node-positive breast cancer: a cohort study.

    Journal of cancer research and clinical oncology·2026
    Same journal

    Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer.

    Journal of cancer research and clinical oncology·2026
    See all related articles

    Effective radiotherapy is crucial for non-metastatic Ewing sarcoma, as chemotherapy cannot replace it. Optimal radiation involves large fields and high doses to normal tissue tolerance, avoiding shrinking fields to prevent recurrence.

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Pediatric Oncology

    Background:

    • Ewing sarcoma is a rare bone cancer primarily affecting children and young adults.
    • Radiotherapy plays a critical role in the multidisciplinary treatment of localized Ewing sarcoma.
    • Optimizing radiotherapy techniques is essential to improve outcomes and minimize toxicity.

    Purpose of the Study:

    • To compare radiotherapy data in non-metastatic Ewing sarcoma patients.
    • To evaluate the effectiveness of different radiotherapy strategies.
    • To identify factors influencing local control and recurrence.

    Main Methods:

    • Retrospective analysis of radiotherapy data from two patient groups.
    • Comparison of treatment outcomes based on irradiation field size and dosage.

    Related Experiment Videos

  • Assessment of recurrence patterns in relation to radiotherapy techniques.

    • Main Results:

    • Intensive chemotherapy does not compensate for inadequate radiotherapy.
    • Large irradiation fields encompassing the entire tumor volume (bone and soft tissues) are necessary.
    • The shrinking field technique is associated with a high risk of marginal recurrences.
    • Higher single doses per fraction and escalated total doses are recommended, within normal tissue tolerance limits.

    Conclusions:

    • Effective radiotherapy is indispensable for non-metastatic Ewing sarcoma.
    • Irradiation fields must be comprehensive, sparing only uninvolved epiphyses.
    • High-dose, large-field radiotherapy is superior to shrinking field techniques.
    • Maximizing radiation dose to the tolerance of surrounding normal tissues is key to preventing local recurrence.